Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-029833
Filing Date
2025-12-31
Accepted
2025-12-31 17:00:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9565
2 EX-1 ex1.htm EX-1 13067
  Complete submission text file 0001493152-25-029833.txt   24379
Mailing Address 575 MADISON AVENUE NEW YORK NY 10022
Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581
LB PHARMACEUTICALS INC (Subject) CIK: 0001691082 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-95235 | Film No.: 251617884
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3455 PEACHTREE ROAD NE, 5TH FLOOR ATLANTA GA 30326
Business Address 3455 PEACHTREE ROAD NE, 5TH FLOOR ATLANTA GA 30326 917-657-2249
Trails Edge Capital Partners, LP (Filed by) CIK: 0002077247 (see all company filings)

EIN.: 331689212 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G